Our laboratory showed for the first time that ALK(+) ALCL cell lines and primary tissues express low levels of miR-29a likely mediated by the hypermethylation of the MIR29A promoter dependent on NPM/ALK activity and STAT3. The gene discussed is ALK; the disease is anaplastic large cell lymphoma.